BMRN - BioMarin may be more of an M&A target with activist Elliott pact - analysts
2023-12-21 11:11:55 ET
More on BioMarin Pharmaceutical
- BioMarin: Keeping Bullish View After Q3 Earnings
- BioMarin Pharmaceutical Inc. 2023 Q3 - Results - Earnings Call Presentation
- Biomarin Pharmaceutical, Inc. (BMRN) Q3 2023 Earnings Call Transcript
- BioMarin establishes strategic review committee, expands board
- BioMarin Pharmaceutical officer disposes stake worth $1.31M under trading plan
For further details see:
BioMarin may be more of an M&A target with activist Elliott pact - analysts